Bridget Howard; Hayden McRobbie; Dennis Petrie; Daniel Barker; Colin Mendelsohn; Jack Anderson; Ron Borland; Felix Naughton; Piotr Tutka; Nick Zwar; Anthony Shakeshaft; Coral Gartner; Robyn Richmond; Wayne Hall; Richard Mattick; Michael Farrell; Ryan James Courtney. Effectiveness, safety and cost-effectiveness of vaporised nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low socioeconomic status Australian population: A study protocol for a randomized controlled trial. Submitted for publication 2022.
Mendelsohn CP, Wodak AD. Which regulatory framework is best for nicotine vaping? Invited editorial. Accepted for publication. American Journal of Public Health 2022
Mendelsohn CP, Gould GS. Unadjusted conversion ratio underestimates nicotine dose. Rapid response letter about ‘Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy’. British Medical Journal. 7 May 2014. http://www.bmj.com/content/348/bmj.g1622/rr/697100
Mendelsohn CP. Misleading message from smoking study. Rapid response letter about ‘Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial’. British Medical Journal, 28 March 2012. http://www.bmj.com/content/344/bmj.e1696/rr/576151